Zum Inhalt springenZur Suche springen

Program 2021

Time
Speaker
Topic

13:00

Prof. Dr. Holger Gohlke

Insitute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University Düsseldorf

Welcome and Introduction

13:10 – 14:00

Dr. Simone Moser

Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich

Phyllobilins - Chlorophyll breakdown as source of bioactive compounds

14:00 – 14:30

Marco Kruppa

Insitute of Organic Chemistry, Heinrich-Heine-University Düsseldorf

Diversity-oriented synthesis of symmetrically and unsymmetrically substituted Alocasin A derivatives against therapy resistant bacteria

14:30 – 15:00

Laura Schmitt

Institute of Molecular Biology I, Heinrich-Heine-University, Düsseldorf

The impact of novel meriolin derivatives on apoptosis and cell cycle progression in leukemia cells

15:00 – 15:15

Short Break

15:15 – 15:55

Dr. Susanne Roehrig

Bayer AG Pharmaceuticals

Discovery and development of the novel antithrombotic agent rivaroxaban, an orally active, direct factor Xa inhibitor

15:55 – 16:45

Prof. Dr. Anna K. H. Hirsch

Department of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS),

Helmholtz Centre for Infection Research &

Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany

Addressing unusual anti-infective targets

16:45 – 17:00

Short Break

17:00 – 17:50

Prof. Dr. Jon Clardy

Blavatnik Institute, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Harvard University, Boston, USA

Chasing molecules and mechanisms in the human gut microbiome

18:00

Holger Gohlke

Closing Remarks

 

Verantwortlichkeit: